Herceptin

The director of the breast cancer program at Houston's M. D. Anderson Cancer Center, Dr. Gabriel Hortobagyi, described the results as revolutionary. The director of breast cancer therapy research at the National Cancer Institute, which funded two of the studies, said the results supported her belief that breast cancer has become curable in more and more women. She admits that the drug treatment is not new, but that it is now effective for a group of women with breast cancer who had a very poor prognosis before, but now have a good one, thanks to the drug. However, Barbara Brenner of the education and advocacy group Brest Cancer Action, thinks the word "cure" is going way too far, since the drug has only been tested in this new group of women for a year or two, which she does not feel is long enough to make such strong statements regarding its success.

. . .
Some common words found in the essay are:
Cancer Institute, Medicine Rubin, Drug Hailed, Drug Administration, breast cancer, Cancer Action, Retrieved Oct, Gabriel Hortobagyi, congestive heart failure, congestive heart, heart failure, References Prevalence, Rubin October, conventional chemotherapy, rubin 2005, Clinical Oncology, her2-positive breast, herceptin conventional, breast cancers, herceptin conventional chemotherapy, women breast cancer, incidence congestive, women received, her2-positive breast cancer, women her2-positive breast,
Approximate Word count = 1019
Approximate Pages = 4 (250 words per page)

More Essays on Herceptin